Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)
| 0.65 Delayed Data As of Jun 05 |  0.00 / 0.00%Today’s Change | 0.50 Today|||52-Week Range 2.41 | -2.55% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 1.9M | 843.0K | 0.00 | 150.0K | |
| Depreciation And Amortization | 210.0K | 133.0K | 32.0K | 29.0K | ||
| Operating Expenses | Gross Income | -- | -- | -32.0K | -- | |
| General Expenses | 17.9M | 14.9M | 9.5M | 9.7M | ||
| Research And Development | 12.2M | 9.3M | 4.2M | 4.3M | ||
| Total Operating Expenses | 18.1M | 15.0M | 9.5M | 9.7M | ||
| Non-Operating Expenses | Operating Income | -16.2M | -14.2M | -9.5M | -9.5M | |
| Extraordinary Charge | -51.0K | 0.00 | 0.00 | 0.00 | ||
| Other Expenses | -274.0K | 339.0K | 910.0K | 592.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -16.5M | -13.8M | -8.5M | -8.6M | |
| Income Taxes | -2.1M | -2.0M | -993.0K | -1.3M | ||
| Preferred Dividend | -201.0K | -200.0K | -7.4M | -201.0K | ||
| Net Income | -14.3M | -11.8M | -7.5M | -7.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.7M | 3.4M | 7.6M | 12.1M | |
| Shares To Calculate EPS Diluted | 2.7M | 3.4M | 7.6M | 12.1M | ||
| Earnings Per Share | EPS | -$5.40 | -$3.50 | -$1.95 | -$0.62 | |
| EPS Diluted | -$5.40 | -$3.50 | -$1.95 | -$0.62 | ||
